Financhill
Back

BeiGene Vs. Theravance Biopharma Industry Stock Comparison

Sell
27

BGNE
BeiGene

Last Price:
144.34
Seasonality Move:
18.09%
Sell
37

TBPH
Theravance Biopharma

Last Price:
9.17
Seasonality Move:
-13.53%
Sell
27
BeiGene (BGNE) is a Sell

Is BeiGene a Buy, Sell or Hold?

  • The current BeiGene [BGNE] share price is $138.99. The Score for BGNE is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • BGNE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
37
Theravance Biopharma (TBPH) is a Sell

Is Theravance Biopharma a Buy, Sell or Hold?

  • The current Theravance Biopharma [TBPH] share price is $9.21. The Score for TBPH is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • TBPH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BGNE Stock Price Chart

What is BeiGene's stock price today?

  • The BeiGene share price today is $138.99
    The current trend is relatively stagnant and BGNE is experiencing slight buying pressure.

TBPH Stock Price Chart

What is Theravance Biopharma's stock price today?

  • The Theravance Biopharma share price today is $9.21
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TBPH is experiencing selling pressure, which indicates risk of future bearish movement.

BGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -7.02 Sell
Relative Strength Index (14 RSI): 41.45 Sell
Chaikin Money Flow: 27615 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (137.37 - 159.63) Sell
Bollinger Bands (100): (147.38 - 177.44) Sell

TBPH Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.1 Buy
Relative Strength Index (14 RSI): 49.13 Sell
Chaikin Money Flow: -255012 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (8.92 - 9.52) Sell
Bollinger Bands (100): (8.74 - 10.56) Sell

BGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 134.63 Buy
20-day SMA: 145.25 Sell
50-day SMA: 154.37 Sell
200-day SMA: 176.87 Sell
8-day EMA: 136.36 Buy
20-day EMA: 143.52 Sell
50-day EMA: 152.33 Sell
200-day EMA: 174.19 Sell

TBPH Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.49 Sell
20-day SMA: 9.3 Sell
50-day SMA: 9.03 Buy
200-day SMA: 9.63 Sell
8-day EMA: 9.38 Sell
20-day EMA: 9.3 Sell
50-day EMA: 9.25 Sell
200-day EMA: 9.67 Sell

BeiGene Earnings Growth & BGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.91 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $4.90 per share.

Theravance Biopharma Earnings Growth & TBPH Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and an increase next year of $0.50 per share.

BeiGene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Theravance Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):